The following is an excerpt from Time. Pfizer Inc.’s vaccine to protect newborns from RSV received backing from U.S. regulatory advisers for use in pregnant mothers to protect their newborns, handing the drugmaker a win in the race to dominate […]
The following is an excerpt from Medpage Today. The FDA has approved the first-ever vaccine for respiratory syncytial virus (RSV) the agency announced on Wednesday. Marketed under the trade name of Arexvy, the adjuvanted RSV prefusion F protein-based vaccine is specifically
FDA green lights first-ever RSV vaccine for adults 60+ Read More »
The CDC is reporting a return to the usual when it comes to the virus that causes common colds. According to a news release today, Respiratory Syncytial Virus (RSV) is returning to the patterns seen prior to Covid-19. Recently, the
CDC: Common cold virus returns to pre-Covid patterns Read More »
The following is an excerpt from MedPage Today. In two somewhat close votes, an FDA panel of outside experts recommended the agency approve Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, despite concerns over the potential risk for Guillain
FDA green lights new Pfizer RSV vaccine amid safety concerns Read More »
The following is an excerpt from Fox News via AOL. With the beginning of winter roughly a week away, major cities across the U.S. are looking to mask up once again for the purpose of combating not just Covid-19, but the flu
The following is an excerpt from The Vaccine Reaction. Amongst frantic media coverage of increases in cases of Respiratory Syncytial Virus (RSV) among children, Pfizer has announced the development of an experimental bivalent RSV vaccine for pregnant mothers in an
Pfizer’s new RSV vaccine for pregnant women on fast track Read More »
The following is an excerpt from the Daily Mail. Children are turning up in doctors’ clinics infected with as many as three different types of viruses, in what experts believe is the result of their immune systems being weakened from
Stanford Scientist Dr. Jay Bhattacharya addresses Covid-19 issues in this order: Lockdowns Fauci and gain-of-function research Lab origins Vaccine passports Natural immunity Antibody Dependent Enhancement Masks RSV virus Children and covid Masks Living normal life Scientists attacked by propaganda campaign
